Troy Pruett, a Grapevine resident, will be competing in his 96th marathon this weekend and getting one step closer to the ...
Shelby Kinsey lives with a rare, fast-progressing form of ALS — but she has to spend her precious time fighting for insurance ...
The Centers for Medicare & Medicaid Services has directed private insurers providing Medicare Advantage plans to cover Biogen ...
It was seven months later when she was diagnosed with amyotrophic lateral sclerosis and bulbar palsy, both neurological ...
People living with motor neuron disease (MND) will have more opportunities to participate in groundbreaking research, thanks ...
Growing up in rural areas, having younger parents, and having less education may all be environmental risk factors for ALS, ...
Corcept Therapeutics’ selective cortisol modulator failed to slow the progress of amyotrophic lateral sclerosis (ALS) in a ...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe e ...
Corcept Therapeutics said on Wednesday its experimental drug failed to meet the main goal of a mid-stage trial in patients ...
Scientists are uncovering new insights into the mechanisms driving neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). These fatal diseases ...
Therapeutics announced it has concluded a Type C meeting with the FDA for PrimeC in the treatment of amyotrophic lateral ...
The U.S. Food and Drug Administration (FDA) signaled that it may be willing to consider granting accelerated approval to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback